Explore meaningful data coverage for more than 1000 cell & gene therapy pipelines from 250 Biopharma, Big Pharma, CMOs, and Research/Academic Institutes in the East-Asia Region. This unique tracker gives you access to broad coverage of both Cell & Gene Therapy Pipeline and Manufacturing, in a single platform.
The data is covered across several parameters to provide real-time insights into cell & gene therapy industry such as the list of CGT companies, cell therapy products, gene therapies, viral & non-viral therapies, allogenic vs autologous therapies, cell & gene therapy pipelines across all stages of development, route of administration for drug candidates and targets, indications, technology platform used in the development, manufacturing of cell and gene therapy products, clinical and commercial production, in-house manufacturing capabilities of cell and gene therapy companies, clinical trial projects, cell and gene therapy manufacturing facilities, production capacity, upstream and downstream processing capabilities, cell therapy processing equipment and technologies and other detailed information on cell and gene therapy developers and manufacturers.
Examples of CGT companies included in this data are JW Therapeutics, Hrain Biotechnology, GenomeFrontier Therapeutics, Takara Bio, Medipost, 3S Bio, MIimmune, Taiwan Biotherapeutics and other top cell & gene therapy companies in the region.
The data is underpinned by user-friendly visuals to allow users to filter through data by cell and gene therapy company, country, product type, cell therapy types, viral vectors types, scale of stage of development, therapy focus area, company founded year, type of company, manufacturing facility location, facility size range, expression system, batch/continuous process, bioreactor type facility operational year, batch size of products and facility counts in a particular country.